Prospektive Studie zur gesundheitsbezogenen Lebensqualität, Sicherheit und Effektivität eines Ethylen-Vinyl-Alkohol Kopolymers (SquidperiTM) in der Behandlung von Patienten mit peripheren highflow Arteriovenösen Malformationen

Prospektive Studie zur gesundheitsbezogenen Lebensqualität, Sicherheit und Effektivität eines Ethylen-Vinyl-Alkohol Kopolymers (SquidperiTM) in der Behandlung von Patienten mit peripheren highflow Arteriovenösen Malformationen

Treatment of arteriovenous malformations (AVM) is technically difficult and aims to occlude pathologic arteriovenous shunts by embolization with liquid embolic agents. Ethylene-Vinyl Alcohol Copolymer (EVOH) has shown excellent results in occluding cerebral AVMs in the neuroradiological field, but until now there is no prospective data in the treatment of peripheral AVMs. In this prospective trail we aim to analyze the therapy-induced changes on health related quality of life of symptomatic AVM patients with a new EVOH agent, which is CE-marked for this indication. Additional outcome parameters are clinical success, safety, feasibility and imaging data. The interdisciplinary study in children and adults is performed at the Interdisciplinary Vascular Anomalies Center, University Clinic Halle (Saale).